e-Newsletter September 2024
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Search results
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Making yourself aware of the what you are entitled to, and understanding the diagnosis pathway for inherited sight loss, will put you in a stronger position to seek better support.
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Inside this edition, set yourself a challenge in 2024, plus find out about our brand new lottery.
An American living with Leber congenital amaurosis 10 (LCA10) has become the first clinical trial participant in the world to receive a CRISPR gene editing treatment in vivo (inside the body).
Researchers have developed PEDF-based eye drops that show promise in slowing retinal degeneration in mice with retinitis pigmentosa, potentially offering a non-invasive treatment option for preserving vision in the future.
Weβre all still buzzing from our recent conferences. We do hope you enjoyed them as much as we did. If you werenβt able to join us, then you can watch or listen to the recordings on our website.
Retina UK invites expressions of interest to their first major innovation grant call, which will result in an award of up to Β£1million over five years as a strategic and targeted investment to result in transformative impact for therapy for inherited retinal dystrophy.
This session will introduce the technique of optogenetics and its potential for development into a treatment for IRDs.
Martin started volunteering for Retina UK in 2014 after retiring as a Chartered Civil Engineer.